Sven de Vos

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Hodgkin Lymphoma

Tyrosine Kinase

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Mark J Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Hendrick-Tobias Arkenau, Sven de Vos, Barret R B Nuttall, Melih Acar, Kathleen Burke, Rafael D White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David F Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, Ian W Flinn
Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, Xavier Poire, Lazaros J Lekakis, Sven de Vos, Craig A Portell, Zixing Wang, Christina To, Marco Schupp, Soumya Poddar, Tan Trinh, Carmen M Warren, Ethan G Aguilar, Justin Budka, Paul Cheng, Justin Chou, Adrian Bot, Rhine R Shen, Jason R Westin
Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7). Blood cancer discovery (2023)
Sarah M Larson, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek, Jacqueline Trent, Jia Ming Chen, Mobina Roshandell, Caitlin M Harris, Mobina Khericha, Thomas Schweppe, Beata Berent-Maoz, Stanley B Gosliner, Amr Almaktari, Melanie Ayala Ceja, Martin S Allen-Auerbach, Jonathan W Said, Karla Nawaly, Monica Mead, Sven de Vos, Patricia A Young, Caspian Oliai, Gary J Schiller, John M Timmerman, Antoni Ribas, Yvonne Y Chen
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer discovery (2022)